Learn more

INST VIRUSOLOGII IM D I IVANOV

Overview
  • Total Patents
    29
About

INST VIRUSOLOGII IM D I IVANOV has a total of 29 patent applications. Its first patent ever was published in 1976. It filed its patents most often in USSR (Union of Socialist Soviet Republics) and Russian Federation. Its main competitors in its focus markets pharmaceuticals are RUGAO DINGBEI HOSPITAL, QIN YUEXIA and GU SEYI.

Patent filings in countries

World map showing INST VIRUSOLOGII IM D I IVANOVs patent filings in countries

Patent filings per year

Chart showing INST VIRUSOLOGII IM D I IVANOVs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals

Focus technologies

# Technology
#1 Medical preparations

Top inventors

# Name Total Patents
#1 Garaev Mansur M 6
#2 Zhdanov Viktor M 5
#3 Novokhatskij Aleksandr S 4
#4 Bobkov Aleksej F 4
#5 Lvov Dmitrij K 3
#6 Zhirnov Oleg P 3
#7 Votyakov Veniamin I 3
#8 Kolomiets Natalya D 3
#9 Bobkova Marina R 2
#10 Klyushnik Sergej Yu 2

Latest patents

Publication Filing date Title
RU2007186C1 Antiseptic agent for prophylaxis of hidu/aids infection
RU1835291C An antiviral means
RU1832331C Method of modelling persistent viral infection
RU1837355C Method for modelling aidъs infections
SU1768637A1 Strain of human immunodeficient virus 1-type for preparation of diagnostic preparation
RU1816797C Recombinant plasmide dna p p1 directed synthesis of fused protein showing antigen properties of human immunodeficiency virus i, method of its constructing and a strain of bacterium escherichia coli - a producer of fused protein showing antigen properties of human immunodeficiency virus i
SU1735363A1 Influenza virus strain a/japan/1/57(h2n1) for modeling infection in mice
SU1751203A1 Strain virus japonici encephalitidis for producing diagnosis and prophylaxis preparations
SU1707074A1 Method for isolation of orthomyxoviruses matrix protein m1
SU1708848A1 Recombinant plasmid dna processing a9, encoding the synthesis of protein with antigenic properties of human deficiency virus of the first type, method for its construction, and the strain of bacteria escherichia coli - a producer of protein with antigenic properties of human immune deficiency virus of the first type
SU1703656A1 Method for isolation of free ribonucleoprotein of influenza virus type a and b
SU1631073A1 Strain of hybrid cultured animal cells mus musculus l employed for preparing monoclonal antibodies to nucleoproteid structural protein of rabies virus
SU1631072A1 Strain of hybrid cultured animal cells mus musculus l employed for producing monoclonal antibodies for glycoproteid structural protein of rabies virus
SU1606533A1 Strain of hepatite virus for producing diagnostic preparations
SU1616991A1 Method of indicating toxigenic corinbacteria of diphtheria
SU1532582A1 Strain of hybrid cultivable mus musculus cells as producer of monoclonal antibody to fever virus
SU1495375A1 Strain of cultivable cells of human hepatocarcinoma defective by timidinikinase for hybridization and trasfection
SU1258416A1 Method of determining markers of virus heratitis
SU1109433A1 Strain of hybrid cam cells used for preparing monoclonic antibodies for tick-borne encephalitis virus
SU1175489A1 Method of obtaining preparation of inactivated surface antigen of hepatitis beta for active immunization